VRTX Gross Profit Growth
Vertex Pharmaceuticals · Gross Profit Growth
VRTX Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported10.47%period ending
VRTX TTM Gross Profit YoY % (100.00% → 10.47%)
Year-over-year change
High-resolution chart · PNG
VRTX gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 10.4675% | |
| 10.7364% | |
| 9.497% | |
| 10.5747% | |
| 10.0696% | |
| 7.9729% | |
| 10.2149% | |
| 7.9111% | |
| 6.8926% | |
| 9.0926% | |
| 9.6377% | |
| 10.7168% | |
| 13.5596% | |
| 15.975% | |
| 17.6931% | |
| 22.1134% | |
| 25.2762% | |
| 23.7434% | |
| 21.9558% | |
| 18.9047% | |
| 23.9608% | |
| 34.3555% | |
| 51.2943% | |
| 68.2151% | |
| 58.4867% | |
| 48.4467% | |
| 37.035% | |
| 27.5367% | |
| 30.5768% | |
| 33.9116% | |
| 19.1786% | |
| 20.2354% | |
| 20.6071% | |
| 16.7202% | |
| 48.3883% | |
| 41.2686% | |
| 39.0742% | |
| 60.6364% | |
| 64.5045% | |
| 111.6126% | |
| 139.1876% | |
| 107.8711% | |
| 74.5755% | |
| -4.7352% | |
| -23.6302% | |
| -39.6412% | |
| -51.9803% | |
| -28.155% | |
| -32.1943% | |
| -20.6668% | |
| -13.2669% | |
| -34.8745% | |
| -40.6598% | |
| -31.676% | |
| -6.2373% | |
| 78.5107% | |
| 616.717% | |
| 808.4815% | |
| 918.1575% | |
| 773.2946% | |
| 161.5492% | |
| 111.4447% | |
| 48.9845% | |
| 14.3722% | |
| 7.4546% | |
| -39.2452% | |
| -45.1332% | |
| -51.8091% | |
| -51.1022% | |
| -9.8588% | |
| -13.6623% | |
| -21.9881% | |
| -21.9422% | |
| -32.5161% | |
| -9.3434% | |
| 31.4697% | |
| 53.5683% | |
| 45.7413% | |
| 35.409% | |
| 36.3798% | |
| 31.5404% | |
| 49.8528% | |
| 55.3468% | |
| 72.3163% | |
| 82.8266% | |
| 66.5271% | |
| 45.6013% | |
| -16.7835% | |
| -34.5942% | |
| -46.397% | |
| -49.8005% | |
| -35.2498% | |
| -28.2961% | |
| -3.4575% | |
| 20.4004% | |
| 70.1667% | |
| 110.9624% | |
| 48.4188% | |
| 48.9662% | |
| -12.4741% |